Cartherics Announces Grant of European Patent
Date posted – 8 March 2021 First patented product to enter clinic within two years Cartherics Pty Ltd (Cartherics) announced today the grant of a European patent entitled “Genetically modified cells and uses thereof”. The patent covers aspects…
Monash University retains its spot as #2 in the world for Pharmacy and Pharmacology
Date posted – 4 March 2021 The 2021 QS World University Rankings by Subject, released today, ranked Monash University number two in the world for Pharmacy and Pharmacology for the second year running. Pharmacy and Pharmacology remains Monash’s…
ALHI $28.9M MRFF GRANT REVOLUTIONISES LUNG FUNCTION SCANNING
Date posted – 4 March 2021 The Australian Lung Health Initiative (ALHI) is pleased to announce it has been granted $28.9 million in funding from the Australian Federal Government’s Medical Research Future Fund (MRFF) Frontier Health and Medical…
Graduate Certificate in Biotechnology (Enterprise) – University of Melbourne
Date posted – 3 March 2021 Graduate Certificate / Year: 2020 / Delivered: Online Be empowered to thrive in the business of biotech The Graduate Certificate in Biotechnology (Enterprise), delivered by The University of Melbourne, allows you to…
The American Chemical Society (ACS) is seeking nominations for C&EN’s 10 Start-ups to Watch
Date posted 3 March 2021 Deadline 1 August 2021 ACS is looking for companies that are using chemistry to solve the world’s most pressing problems. Firms that have made our list are developing pharmaceuticals, materials, green chemistry processes,…
Monash University and PureTech Health develop novel technology platform that targets drugs to the lymphatics and lymph nodes
Date posted – 26 February 2021 Researchers from the Monash Institute of Pharmaceutical Sciences (MIPS) and PureTech Health (LSE: PRTC, Nasdaq: PRTC) have developed a novel technology platform that directly targets gut lymphatics and has great potential to…
Medical devices reforms: Personalised medical devices
25 February 2021 Please note: While submission of a notification to the TGA is required within two (2) months of initial manufacture/supply of a custom-made medical device, many stakeholders have not been meeting this obligation. If you were supplying…
VivaZome and La Trobe University enter new research collaboration to develop exosome therapeutics.
16 February 2021 VivaZome Therapeutics Pty Ltd (“VivaZome”) and La Trobe University today announced that they have entered into a new collaborative research project focussed on developing novel exosome therapeutics. Under the collaborative arrangement, VivaZome scientists will work…
TGA approves first Australian commercial CAR-T manufacturing site – bringing faster access to eligible Australians with life-threatening blood cancers
12 February 2021 • Kymriah® (tisagenlecleucel)[pronounced kim-RY-uh], a chimeric antigen receptor T cell (CAR-T) one-time treatment, will be the first commercially approved CAR-T therapy to be manufactured in Australia • Providing manufacturing capabilities in Australia will help reduce…
New appointments at Biointelect
12 February 2021 Biointelect has made several new appointments to its Sydney and Melbourne-based teams as it experiences strong growth across all its three main consulting workstreams: R&D strategy and planning, biotech commercialisation and strategic market access, health…
First-hand experience sparks Rhinomed to develop high comfort swab
Posted 10 December 2020 This is a BioMelbourne Network Good News Story – click here to find out more and submit yours. In April this year, as the world came to grips with the global COVID-19 pandemic, Rhinomed CEO Michael…
Monash University partners with HuiKang Bio-Tech to develop new class of anti-infectives
7 December 2020 Monash University has announced a collaboration with leading protein and peptide experts, HuiKang Bio-Tech, to develop a new class of anti-infectives. The collaboration is being led by Professor Ray Norton from the Monash Institute of…
